bepmed |

102726646
l 2012
CN

7321. Oral liquid preparation having effects of expelling and removing toxins

Abstract

The invention discloses an oral liquid preparation having effects of expelling and removing toxins. The oral liquid preparation is prepared from 38 to 44g of...

13:47 / rest

102727931
l 2012
CN

7322. Construction and preparation of three-dimensional bionic electropolarized gradient pore nerve conduit

Abstract

The invention provides construction and preparation of a three-dimensional bionic electropolarized gradient pore nerve conduit. The nerve conduit is an electropolarized beta-tricalcium phosphate/polylactic acid/hyaluronic acid/chitosan/nerve...

13:47 / rest

2012138732
l 2012
WO

7323. BIOCOMPATIBLE POLYCAPROLACTONE FUMARATE FORMULATIONS

Abstract

A polycaprolactone fumarate polymer useful as a matrix material for a biocompatible scaffold for tissue engineering applications is disclosed. The polycaprolactone fumarate polymer can be...

13:47 / methods / Scaffolds

2012259415
l 2012
US

7324. STRUCTURALLY MODIFIED ACELLULAR TISSUE ENGINEERING SCAFFOLDS AND METHODS OF PRODUCTION

Abstract

Methods are provided for producing a bioscaffold from natural tissues by oxidizing a decellularized tissue to produce a bioscaffold having pores therein. The pore size...

13:47 / methods / Scaffolds

2012258160
l 2012
US

7325. CHEMICALLY MODIFIED CELLULOSE FIBROUS MESHES FOR USE AS TISSUE ENGINEERING SCAFFOLDS

Abstract

Cellulose and sulfated cellulose fibrous meshes exhibiting robust structural and mechanical integrity in water were fabricated using a combination of electrospinning, thermal-mechanical annealing and chemical...

13:47 / growth factors / Scaffolds

102725308
l 2012
CN

7326. Fibronectin: growth factor chimeras

Abstract

Isolated protein complexes are provided comprising growth factors such as IGF-I, IGF-II, EGF, bFGF, or KGF and fibronectin, or at least domains thereof that enable...

13:47 / growth factors / methods

102721814
l 2012
CN

7327. F protein detection reagent and detection method therefor

Abstract

The invention relates to an F protein detection reagent and a detection method therefor. The F protein detection reagent comprises rabbit anti-human polyclonal antibodies of...

13:47 / cells / methods

102755666
l 2012
CN

7328. Application of basic fibroblast growth factor to improvement of tissue engineered heart conduction bundle deformation

Abstract

The invention relates to the technical field of biomedical engineering. The inventor builds a tissue engineered conduction bundle which consists of an embryonic heart progenitor...

13:47 / growth factors / methods

102755203
l 2012
CN

7329. Spraying and coating combined complex tissue organ manufacturing system

Abstract

The invention discloses a spraying and coating combined complex tissue organ manufacturing system which belongs to the technical field of tissue engineering. The spraying and...

13:47 / organ / system

102755204
l 2012
CN

7330. Novel assembly type keratoprosthesis

Abstract

The invention relates to the field of biomedical engineering, and in particular relates to a novel assembly type keratoprosthesis. The assembly type keratoprosthesis provided by...

13:47 / rest

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract